Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 33, 2001 - Issue 12
Submit an article Journal homepage
43
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Efficacy of Short-course Therapy with the Ketolide Telithromycin Compared with 10 Days of Penicillin V for the Treatment of Pharyngitis/Tonsillitis

S. Ragnar Norrby, Willem J. Rabie, Patrick Bacart, Otmar Mueller, Bruno Leroy, Manickam Rangaraju, Emmanuelle Butticaz-Iroudayassamy
Pages 883-890 | Published online: 08 Jul 2009

  • Linder JA, Stafford RS. Antibiotic treatment of adults with sore throat by community primary care physicians. A national survey, 1989–1999. J Am Med Assoc 2001; 286: 1181–6.
  • Gwaltney JM. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and practice of infectious disease, 3rd edn. New York: Churchill Livingstone, 1990: 493–8.
  • Dajani A, Taubert K, Ferrieri P, Peter G, Shulman S. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Pediatrics 1995; 96: 758–64.
  • Bartlett JG. IDCP guidelines: management of upper respiratory tract infections. Infect Dis Clin Pract 1997; 6: 212–20.
  • Pichichero ME, Cohen R. Shortened course of antibiotic therapy for acute otitis media, sinusitis and tonsillopharyngitis. Pediatr Infect Dis J 1997; 16: 680–95.
  • Gerber MA, Randolph MF, Chanatry J, Wright LL, de Meo K, Kaplan EL. Five vs ten days of penicillin V therapy for streptococcal pharyngitis. Am J Dis Child 1987; 141: 224–7.
  • Schwartz RH, Wientzen RL, Pedreira F, Feroli EJ, Mella GW, Guandolo VL. Penicillin V for group A streptococcal pharyngotonsillitis. A randomized trial of seven vs ten days’ therapy. J Am Med Assoc 1981; 246: 1790–5.
  • Pichichero ME, Casey JR, Mayes T, Francis AB, Marsocci SM, Murphy AM, et al. Penicillin failure in streptococcal tonsillopharyngitis: causes and remedies. Pediatr Infect Dis J 2000; 19: 917–23.
  • Barry AL, Fuchs PC, Brown SD. In vitro activities of the ketolide HMR 3647 against recent Gram-positive clinical isolates and Haemophilus influenzae. Antimicrob Agents Chemother 1998; 42: 2138–40.
  • Betriu C, Gomez M, Redondo M, Sanchez A, Palau ML, Picazo JJ. In vitro activity of the ketolide HMR 3647 against Streptococcus pyogenes. Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, 26–29 September, 1999, San Francisco, CA. Washington, D.C.: American Society for Microbiology, 1999: Abstract No. 1250.
  • Cocuzza CE, Tomasin A, Renzetti D, Primavera A, Santini L, Marchetti F, et al. Ketolide (HMR 3647) in vitro activity on 4000 strains of Streptococcus pyogenes isolated in northern Italy. Abstracts of the 4th International Conference on the Macrolides, Azalides, Streptogramins and Ketolides, 21–23 January, 1998, Barcelona, Spain, Abstract No. 1.06.
  • Descheemaeker P, Chapelle S, Lammens C, Hauchecorne M, Wijdooghe M, Vandamme P, et al. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates. J Antimicrob Chemother 2000; 45: 167–73.
  • Hoban D, Palatnick L, Weshnoweski B, Cox L, Balko T, Karlowsky J, et al. The novel ketolide HMR 3647 is highly active against worldwide isolates of Streptococcus pneumoniae and Streptococcus pyogenes. Abstracts of the 4th International Conference on the Macrolides, Azalides, Streptogramins and Ketolides, 21–23 January, 1998, Barcelona, Spain, Abstract No. 1.04.
  • Giovanetti E, Montanari MP, Mingoia M, Varaldo PE. In vitro activity of ketolides telithromycin and HMR 3004 against Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility. J Antimicrob Chemother 2000; 46: 905–8.
  • Lenfant B, Sultan E, Wable C, Pascual MH, Meyer BH, Scholtz HE. Pharmacokinetics of 800 mg once-daily oral dosing of the ketolide, HMR 3647, in healthy young volunteers. Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, 24–27 September, 1998, San Diego, CA. Washington, D.C.: American Society for Microbiology, 1998: Abstract No. A–49.
  • Gehanno P, Passot V, Nabet P, Sultan E. Telithromycin (HMR 3647) penetrates rapidly into tonsillar tissue achieving high and prolonged tonsillar concentrations. Clin Microbiol Infect 2000; 6 (Suppl 1): 204 (Abstract No. MoP251).
  • Efstratiou A. Group A streptococci in the 1990s. J Antimicrob Chemother 2000; 45 (Suppl): 3–12.
  • Garau J, Barry B, Butzler J-P, Dagan R, Pelton SI. Upper respiratory tract infections: etiology, current treatment, and experience with fluoroquinolones. Clin Microbiol Infect 1998; 4 (Suppl 2): 51–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.